✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Alnylam Pharmaceuticals Inc

Common Name
Alnylam Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,500
Ticker
ALNY
Exchange
NASDAQ/NGS
Description
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root ca...

Disclosures of Alnylam Pharmaceuticals

Explore Alnylam Pharmaceuticals's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Alnylam Pharmaceuticals's official channels and fully traceable to its official company sources.

The table below lists all of Alnylam Pharmaceuticals's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Alnylam Pharmaceuticals's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Corporate Responsibility Report (CRR)
2024
Financial & Extra-Financial Disclosure
2024
Annual Report
2024
10-K
2024
Financial & Extra-Financial Disclosure
2023
Corporate Responsibility Report (CRR)
2023
Annual Report
2023
10-K
2022
Corporate Responsibility Report (CRR)
2022
10-K
2021
Corporate Responsibility Report (CRR)
2021
10-K
2020
Annual Report
2020
Corporate Responsibility Report (CRR)
2020
10-K
2019
10-K
2018
10-K
2017
10-K
2016
10-K
2015
10-K
2014
10-K
2013
10-K
2012
10-K
2011
10-K
2010
10-K
2009
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?